Product NDC: | 0591-2919 |
Proprietary Name: | levalbuterol hydrochloride |
Non Proprietary Name: | levalbuterol hydrochloride |
Active Ingredient(s): | .63 mg/3mL & nbsp; levalbuterol hydrochloride |
Administration Route(s): | RESPIRATORY (INHALATION) |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0591-2919 |
Labeler Name: | Watson Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020837 |
Marketing Category: | NDA |
Start Marketing Date: | 20120820 |
Package NDC: | 0591-2919-23 |
Package Description: | 2 POUCH in 1 CARTON (0591-2919-23) > 12 VIAL, SINGLE-DOSE in 1 POUCH (0591-2919-39) > 3 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 0591-2919-23 |
Proprietary Name | levalbuterol hydrochloride |
Package Description | 2 POUCH in 1 CARTON (0591-2919-23) > 12 VIAL, SINGLE-DOSE in 1 POUCH (0591-2919-39) > 3 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 0591-2919 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | levalbuterol hydrochloride |
Dosage Form Name | SOLUTION |
Route Name | RESPIRATORY (INHALATION) |
Start Marketing Date | 20120820 |
Marketing Category Name | NDA |
Labeler Name | Watson Laboratories, Inc. |
Substance Name | LEVALBUTEROL HYDROCHLORIDE |
Strength Number | .63 |
Strength Unit | mg/3mL |
Pharmaceutical Classes | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |